A GnRH conjugate that demonstrated rapid accumulation in both breast and prostate tumors, and specific binding to the GnRH receptor was developed and provided an efficient visualization of cancer lesions by SPECT (95, 98). This evidence concerns the gene GNRHR and cancer.